Literature DB >> 1928269

A review of bacterial keratitis and bacterial conjunctivitis.

M B Limberg.   

Abstract

Bacterial keratitis is an opportunistic infection of the avascular corneal stroma, initiated by a breakdown of the epithelial barrier. Corneal abrasion with infected material, extended-wear contact lenses, eyelid disease, and disorders of the ocular surface are predominant contributing factors. Acute bacterial conjunctivitis occurs when sufficient bacteria are introduced into the fornices to overwhelm normal bacteriostatic and flushing mechanisms. Chronic conjunctivitis is associated with a constant adnexal source of bacteria and resolves when the source is successfully treated. Rapid diagnosis and treatment of bacterial keratitis are essential to limit stromal scarring and minimize visual loss.

Entities:  

Mesh:

Year:  1991        PMID: 1928269

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection.

Authors:  Atsuko Hayashida; Shiro Amano; Richard L Gallo; Robert J Linhardt; Jian Liu; Pyong Woo Park
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

2.  [Therapy-resistant purulent keratoconjunctivitis].

Authors:  D Karimdadian; N Feltgen; H Hoerauf
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

Review 3.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

Review 4.  Bacterial conjunctivitis.

Authors:  John Epling
Journal:  BMJ Clin Evid       Date:  2012-02-20

5.  Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense.

Authors:  Atsuko Hayashida; Shiro Amano; Pyong Woo Park
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

6.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 7.  Bacterial conjunctivitis.

Authors:  John Epling
Journal:  BMJ Clin Evid       Date:  2010-03-15

8.  Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.

Authors:  M C Callegan; L S Engel; J M Hill; R J O'Callaghan
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Acute infectious conjunctivitis in childhood.

Authors:  R Chawla; J D Kellner; W F Astle
Journal:  Paediatr Child Health       Date:  2001-07       Impact factor: 2.253

10.  Simplifying collection of corneal specimens in cases of suspected bacterial keratitis.

Authors:  Stephen B Kaye; Prasad G Rao; Godfrey Smith; John A Scott; Sharon Hoyles; Clare E Morton; Colin Willoughby; Mark Batterbury; Graham Harvey
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.